Rx Propellant becomes a part of the Actis portfolio
Rx Propellant has been acquired by Actis – a UK based global investment company for an initial USD 200 million investment in May 2022. This investment places a focus on sustainability in life science clusters in the cities of Hyderabad, Bengaluru and Mumbai.
Rx Propellant announces the launch of 9 lakh sqft of lab spaces in Hyderabad
Hyderabad, October 18, 2022: India’s leading life sciences infrastructure and cluster developers, Rx Propellant, on Tuesday announced the launch of 9 lakh sqft of lab spaces in Genome Valley of Hyderabad. The foundation stones for two new projects, B-hub and GV1, were laid by Industries & Commerce Minister K.T. Rama Rao.
Meeting to boost collaboration in life sciences held in Hyderabad
Hyderabad, February 23, 2023: A meeting seeking to promote collaboration in life sciences and serve as a networking platform for researchers, entrepreneurs and industry professionals was conducted on Thursday at Genome Valley.
Rx Propellant, Roach Lifescapes to set up life sciences cluster in Bengaluru
Bengaluru, March 15, 2023: Rx Propellant in partnership with Roach Lifescapes, plans to set up a 52-acre campus, Bengaluru Lifesciences Research (BLR) District, in Attibele, Bengaluru. The project comprises lab space modules and built-to-suit flexi factories catering to the biopharma, medtech, agriscience, nutraceutical, and allied sectors.